Technetium-99m (Tc-99m) is a radioisotope of technetium that is widely used in medical imaging and diagnostic procedures. It is particularly valuable in nuclear medicine due to its favorable characteristics: 1. **Half-Life**: Tc-99m has a relatively short half-life of about 6 hours, which is ideal for medical applications as it minimizes radiation exposure to patients while allowing sufficient time for imaging procedures.
Bectumomab is a monoclonal antibody that was developed for use in the treatment of certain types of cancer, particularly non-Hodgkin lymphoma. It specifically targets the CD19 antigen, which is commonly expressed on the surface of B-cell lymphoid malignancies. By binding to CD19, Bectumomab may help to direct the immune system's response against cancer cells, potentially leading to their destruction.
Myocardial perfusion imaging (MPI) is a non-invasive diagnostic technique used to assess blood flow to the heart muscle (myocardium). It helps evaluate the presence and severity of coronary artery disease (CAD) by visualizing how well blood is being delivered to different areas of the heart. The procedure typically involves the use of a radioactive tracer, which is injected into the bloodstream. This tracer emits gamma rays that can be detected by a specialized camera, creating images of the heart.
Sodium pertechnetate (Na^99TcO₄) is a chemical compound that contains the isotope technetium-99 (Tc-99), which is a radioactive element. It is typically found in the form of a sodium salt and has various applications, primarily in the field of nuclear medicine.
Technetium-99m albumin aggregated (99mTc-WBC) is a radiopharmaceutical used in medical imaging, particularly in nuclear medicine. It consists of technetium-99m, a radioactive isotope of technetium, that is bound to aggregated human serum albumin (HSA). The aggregation of albumin enhances its uptake by the reticuloendothelial system, specifically in tissues such as the liver, spleen, and bone marrow.
Technetium (99mTc) arcitumomab is a radiopharmaceutical used in medical imaging, particularly in nuclear medicine. It is a monoclonal antibody that is labeled with the radioisotope technetium-99m, which is commonly used for various diagnostic imaging procedures.
Technetium (99mTc) exametazime, often referred to as Tc-99m exametazime or merely exametazime, is a radiopharmaceutical used in medical imaging, particularly in single-photon emission computed tomography (SPECT) scans. It is a complex of technetium-99m, a radioisotope, with a radiolabeled agent that binds to brain tissues.
Technetium (99mTc) fanolesomab is a radiolabeled monoclonal antibody that was developed for diagnostic imaging purposes, particularly in the context of detecting inflammation and certain infections in the body. It binds specifically to the surface receptor CD11b, which is found on the surface of activated leukocytes (white blood cells).
Technetium (99mTc) mebrofenin is a radiopharmaceutical used in medical imaging, specifically in hepatobiliary scanning to assess liver and gallbladder function. It is a complex formed by the radiolabeling of mebrofenin, a compound that is a derivative of iminodiacetic acid (IDA).
Technetium (99mTc) medronic acid is a radiopharmaceutical used primarily in diagnostic imaging, particularly in bone scans. The compound consists of technetium-99m (a radioisotope of technetium) bound to medronic acid (also known as methylenediphosphonic acid or MDP), which is a bisphosphonate compound.
Technetium (99mTc) mertiatide is a radiopharmaceutical used primarily in medical imaging, particularly in the field of nuclear medicine. It is a technetium-based compound that is utilized for its ability to target and visualize certain tissues or organs within the body.
Technetium (99mTc) nofetumomab merpentan is a radiopharmaceutical used in medical imaging, particularly in the diagnosis of certain conditions involving lymph nodes. It is a combination of a radioactive technetium isotope (technetium-99m) and a monoclonal antibody fragment (nofetumomab), which targets specific markers on the surface of certain cells, allowing for enhanced visualization of lymphatic tissue.
Technetium (99mTc) pentetic acid is a radiopharmaceutical compound used primarily in nuclear medicine for diagnostic imaging. It consists of technetium-99m, a radioisotope of technetium that emits gamma radiation, combined with pentetic acid (also known as diethylenetriaminepentaacetic acid, or DTPA), which acts as a chelating agent.
Technetium (99mTc) pintumomab is a radiolabeled monoclonal antibody used primarily in the field of nuclear medicine for imaging purposes. It is designed to target specific antigens in order to visualize certain types of tissues or tumors in the body, particularly in the context of cancer diagnostics. Here’s a breakdown of its components: 1. **Technetium (99mTc)**: This is a radioactive isotope of technetium that emits gamma rays.
Technetium-99m (99mTc) sestamibi is a radioactive tracer used in nuclear medicine, particularly in the field of imaging and diagnostics. It is a complex of the radioisotope technetium-99m with the compound sestamibi (mibi stands for methoxyisobutylisonitrile), which is a lipophilic cation that preferentially accumulates in viable myocardial tissue due to its affinity for cells with high mitochondrial activity.
Technetium (99mTc) sulesomab is a radiopharmaceutical agent used in nuclear medicine for imaging purposes, particularly in the diagnosis of certain types of infections and inflammatory conditions. It is a monoclonal antibody that is tagged with technetium-99m, a radioactive isotope commonly used in various imaging procedures.
Technetium (99mTc) tetrofosmin is a radiopharmaceutical compound used primarily in nuclear medicine for diagnostic imaging, particularly in myocardial perfusion imaging (MPI). It is a technetium-labeled agent that targets the heart muscle, allowing for the evaluation of blood flow to the myocardium.
Technetium (99mTc) tilmanocept is a radiopharmaceutical used primarily in medical imaging. Specifically, it is used in lymphatic imaging to help visualize lymphatic pathways and lymph nodes in patients, particularly in the context of cancer diagnosis and surgical planning. Tilmanocept is a receptor-targeted imaging agent that binds to the mannose receptor, which is present on macrophages.
Articles by others on the same topic
There are currently no matching articles.